Search
Search Results
##search.searchResults.foundPlural##
-
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3499PDF: 1060HTML: 3041 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2515PDF: 1939HTML: 1095 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2361PDF: 1107HTML: 4125Cover Letter: 287Figure 1: 289Figure 2: 277Table 1: 263 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2513PDF: 817HTML: 2160Untitled: 293Untitled: 201Untitled: 236Untitled: 215Untitled: 234Untitled: 248Untitled: 239 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1260PDF: 1259Suppl. Files: 607HTML: 117 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3524PDF: 1037HTML: 4983 -
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
974PDF: 184HTML: 235 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
2113PDF: 889HTML: 2234Table 1: 234Table 2: 251Table 3: 247Table 4: 246Table 5: 259Tble 6: 239Cover Letter: 258Greene Tab.7: 261 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
3313PDF: 977HTML: 6634Untitled: 293Untitled: 250Untitled: 272Untitled: 278 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
2329PDF: 1197HTML: 10772Untitled: 248 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1297PDF: 894HTML: 3429 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2363PDF: 938HTML: 388 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3767PDF: 1649HTML: 4564CoverLetter: 290Figure1: 308 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1656PDF: 1037HTML: 272 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2855PDF: 850HTML: 2338 -
INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS
2011PDF: 1160HTML: 316 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2685PDF: 1427HTML: 1875CoverLetter: 237 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2855PDF: 1142HTML: 5147Cover Letter: 212Figure 2: 217Figure 1: 225Figure 3: 251Figure 4: 247Figure Legend: 237Table 1: 249Table 2: 230Table 3: 225 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1649PDF: 1357HTML: 546 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3863PDF: 2668HTML: 1716 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2769PDF: 1755HTML: 2469Table1: 297 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3897PDF: 997HTML: 6897 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1762PDF: 1206HTML: 278 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1477PDF: 588HTML: 312 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1264PDF: 596HTML: 404 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4738PDF: 1834HTML: 1401 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2449PDF: 1140HTML: 2041Characteristic of study group: 264 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2769PDF: 892HTML: 5404 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
2348PDF: 918HTML: 273 -
Mantle cell lymphoma relapsing at the lymphedematous arm.
1813PDF: 767HTML: 3852 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4724PDF: 1596HTML: 8562 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2377PDF: 1739HTML: 752 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
2052PDF: 1267HTML: 356 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2653HTML: 365PDF: 987







